Shahzad Malik - Net Worth and Insider Trading

Shahzad Malik Net Worth

The estimated net worth of Shahzad Malik is at least $2 Million dollars as of 2024-11-13. Shahzad Malik is the Director, 10% Owner of Conatus Pharmaceuticals Inc and owns about 4,054,927 shares of Conatus Pharmaceuticals Inc (CNAT) stock worth over $2 Million. Shahzad Malik is the Director of Iterum Therapeutics PLC and owns about 57,877 shares of Iterum Therapeutics PLC (ITRM) stock worth over $85,658. Shahzad Malik is also the Director of Aravive Inc and owns about 271,794 shares of Aravive Inc (ARAV) stock worth over $10,899. Besides these, Shahzad Malik also holds Agenus Inc (AGEN) . Details can be seen in Shahzad Malik's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Shahzad Malik has not made any transactions after 2018-05-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Shahzad Malik

To

Shahzad Malik Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Shahzad Malik owns 7 companies in total, including Acutus Medical Inc (AFIB) , Iterum Therapeutics PLC (ITRM) , and Aravive Inc (ARAV) among others .

Click here to see the complete history of Shahzad Malik’s form 4 insider trades.

Insider Ownership Summary of Shahzad Malik

Ticker Comapny Transaction Date Type of Owner
AFIB Acutus Medical Inc 2020-08-05 director
ITRM Iterum Therapeutics PLC 2019-06-13 director
ARAV Aravive Inc 2019-09-12 director
LIMIT LIMIT 2018-10-30 director & 10 percent owner
LIMIT LIMIT 2013-07-24 director & 10 percent owner
LIMIT LIMIT 2015-04-29 director
LIMIT LIMIT 2007-06-14 director

Shahzad Malik Latest Holdings Summary

Shahzad Malik currently owns a total of 4 stocks. Among these stocks, Shahzad Malik owns 4,054,927 shares of Conatus Pharmaceuticals Inc (CNAT) as of July 30, 2013, with a value of $2 Million and a weighting of 95.92%. Shahzad Malik owns 57,877 shares of Iterum Therapeutics PLC (ITRM) as of May 30, 2018, with a value of $85,658 and a weighting of 3.62%. Shahzad Malik also owns 271,794 shares of Aravive Inc (ARAV) as of March 17, 2017, with a value of $10,899 and a weighting of 0.46%. The other 1 stocks Agenus Inc (AGEN) have a combined weighting of 0% among all his current holdings.

Latest Holdings of Shahzad Malik

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CNAT Conatus Pharmaceuticals Inc 2013-07-30 4,054,927 0.56 2,270,759
ITRM Iterum Therapeutics PLC 2018-05-30 57,877 1.48 85,658
ARAV Aravive Inc 2017-03-17 271,794 0.04 10,899
AGEN Agenus Inc 2015-04-29 0 3.11 0

Holding Weightings of Shahzad Malik


Shahzad Malik Form 4 Trading Tracker

According to the SEC Form 4 filings, Shahzad Malik has made a total of 0 transactions in Conatus Pharmaceuticals Inc (CNAT) over the past 5 years. The most-recent trade in Conatus Pharmaceuticals Inc is the sale of 535 shares on July 30, 2013, which brought Shahzad Malik around $5,885.

According to the SEC Form 4 filings, Shahzad Malik has made a total of 0 transactions in Iterum Therapeutics PLC (ITRM) over the past 5 years. The most-recent trade in Iterum Therapeutics PLC is the acquisition of 15,799 shares on May 30, 2018, which cost Shahzad Malik around $3 Million.

According to the SEC Form 4 filings, Shahzad Malik has made a total of 0 transactions in Aravive Inc (ARAV) over the past 5 years. The most-recent trade in Aravive Inc is the sale of 80,612 shares on March 17, 2017, which brought Shahzad Malik around $9 Million.

More details on Shahzad Malik's insider transactions can be found in the Insider Trading History of Shahzad Malik table.

Insider Trading History of Shahzad Malik

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Shahzad Malik Trading Performance

GuruFocus tracks the stock performance after each of Shahzad Malik's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Shahzad Malik is -16.21%. GuruFocus also compares Shahzad Malik's trading performance to market benchmark return within the same time period. The performance of stocks bought by Shahzad Malik within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Shahzad Malik's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Shahzad Malik

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -12.18 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -11.97 LIMIT LIMIT LIMIT LIMIT LIMIT

Shahzad Malik Ownership Network

Ownership Network List of Shahzad Malik

No Data

Ownership Network Relation of Shahzad Malik

Insider Network Chart

Shahzad Malik Owned Company Details

What does Acutus Medical Inc do?

Who are the key executives at Acutus Medical Inc?

Shahzad Malik is the director of Acutus Medical Inc. Other key executives at Acutus Medical Inc include Interim CFO Takeo Mukai , SVP & Global Sales Kevin Mathews , and Chief People Officer Charlie Piscitello .

Acutus Medical Inc (AFIB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Acutus Medical Inc (AFIB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acutus Medical Inc (AFIB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Acutus Medical Inc (AFIB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Acutus Medical Inc Insider Transactions

No Available Data

Shahzad Malik Mailing Address

Above is the net worth, insider trading, and ownership report for Shahzad Malik. You might contact Shahzad Malik via mailing address: 2273 Research Blvd, Suite 400, Rockville Md 20850.